The therapeutic candidate is under development for the treatment of liver fibrosis and KRAS-driven liver cancer. It is an antisense RNAi oligonucleotide delivered through lipid-nanoparticles and is ...
Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating recurrent or refractory ascites due to liver cirrhosis. This approval marks Alfapump as the first active ...
BNP Chairperson Khaleda Zia will travel to London on Tuesday (7 January) night for advanced medical treatment, party Secretary General Mirza Fakhrul Islam Alamgir formally announced today (5 January).
Bangladesh Nationalist Party (BNP) Chairperson and former Prime Minister Begum Khaleda Zia will leave for London on January 7 for treatment. BNP Secretary General Mirza Fakhrul Islam Alamgir made the ...